субота, 23 липня 2016 р.

Treat rheumatic patients in Russia have become a new way

Over the past five years electronic terminals self patients were established at 14 rheumatology centers in 13 regions of the country. With these technical devices, patients begin to communicate with the doctors before the start of the reception - virtually. Coming to the consultation, the patient in advance with the help of a nurse enters into the terminal on your personal page answers questions as health. Specialized clinical questionnaire drawn up by the international Standards of Rheumatology.

 Treat rheumatic patients in Russia have become a new way  rheumatology


These innovations make it possible not only more actively use the international principle of Rheumatology "Treatment to achieve the goal »(Treat to Target, T2T), but also saves time doctor. This is important, because at the reception given to the expert in the regulations rather a limited amount of time. A program embedded in the terminal is capable of automatically calculate the indices of disease activity and quality of life, which are needed to assess the effectiveness of the therapy by doctors and its correction. Not wasting time on a detailed survey of the patient and on the record in the out-patient card, the doctor conducts the necessary examination of the patient and assigns treatment. The possibility of medical errors while substantially minimized.

Terminals have been able to use more than 1,100 patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. Total online was filled more than 8, 000 clinical questionnaires.

To organize this project, it was necessary first to teach doctors and nurses. Through the efforts of Russian Association of Rheumatology (APP), and autonomous companies AbbVie non-profit organization "Center for training health care professionals" in for five years to develop the project "rheumatological nursing service" "Virtual hospital" and "Development of the use of ultrasound diagnostics Russian rheumatology. " (READ MORE)
Oksana Herasymenko




Industry News

Go back to the main page

Немає коментарів:

Дописати коментар